Global Eye Melanoma Market at an approximate CAGR of 7.8% during the forecasted period 2019-2023. Eye Melanoma Market Research Report: By Site (Sclera, Retina, Uvea), By Diagnosis (Eye Exam, Imaging, Biopsy), Treatment (Radiation Therapy, Laser Treatment, Surgery), End User (Hospitals & Clinics, Academic Institutes) – Global Forecast Till 2023
Eye Melanoma or ocular melanoma is a form of cancer that is developed in pigment producing cells of the eye. Ocular melanoma can develop in any three layers of the eye i.e. the uvea, retina and sclera. Ocular melanoma has symptoms like dark spot on the iris or conjunctiva, blurred or distorted vision, sensation of flashing light , and change in the shape of pupil. The treatment includes trans pupillary thermotherapy, surgical resection techniques and laser techniques. The global market for eye melanoma is growing owing to increase prevalence of eye cancer in geriatric population.
According to American Cancer society, 3,540 new cases and 350 deaths are estimate to occur mainly because of melanoma of the eye and orbit n 2018.
Increasing prevalence of the eye cancer, growing geriatric population, rising healthcare expenditures, and increasing research and development investments by the major players of the market are the major driver for the market growth. On the other hand factors such as lack of awareness, high diagnostics, and surgical procedures costs are projected to restrain the market growth during the estimated period. Laser iridotomy is estimated to cost around USD 1,068 to USD 1,188.
To Get Free Sample Copy of Report visit https://www.marketresearchfuture.com/sample_request/5570
According to the Office for National Statistics, the geriatric population within the U.K is approximate to increase from 65.6 billion in 2016 to 69.8 billion by 2026. Global eye melanoma market is expected to grow at CAGR of 7.8% during the forecasted period 2017-2023
Key Players for Global Eye Melanoma Market
Market Research Future (MRFR) recognizes the following companies as the key players in Eye Melanoma Market: There are plenty of large and small market players which operate in this market all over the globe.
- Castle Biosciences, Inc. (U.S.),
- GENERAL ELECTRIC (U.S.),
- Koninklijke Philips N.V. (The Netherlands),
- TOSHIBA CORPORATION(Japan),
- Siemens AG (Germany),
- Analogic Corporation (U.S.),
- Optovue Incorporated (U.S.),
- NOVADAQ Technologies Inc. (Canada),
- Bellicum Pharmaceutical (U.S.),
- Immunocare (U.K.)
- Astra Zeneca Plc (U.S.),
- Agfa-Gevaert Group (Belgium), and
- ZEISS (Germany)
are some of the prominent players at the forefront of competition in Eye Melanoma market.
The market is developing in America due to strong healthcare sector. The key companies such as Castle Biosciences Inc., GENERAL ELECTRIC, Optovue Incorporated, Immunocare, Astra Zeneca Plc are engaged in manufacturing and development of various diagnostics systems, imaging system, treatment medications to increase its market penetration in eye melanoma market.
Castle Biosciences Inc. is engaged in developing diagnostic tests and prognostic tests for cancers headquartered in U.S. The company’s key areas for research and development are cutaneous melanoma, uvea melanoma, esophageal adenocarcinoma, mesothelioma and glioma.
In March 2018 the company announced inclusion of DecisionDx-UM prognostic test class results in National Comprehensive Cancer Network (NCCN), New guidelines for Uvea Melanoma.
Optovue Inc. is a privately held ophthalmic device company that designs, develops, manufactures, and sells spectral-domain optical coherence tomography (OCT) devices in U.S. and other emerging market segments. The diagnostic tools helps in visualization of the eye, which helps in management of the disease. The company’s main product is Angio Vague Imagining system.
Analogic Corporation Company is involved in developing, manufacturing, and selling ultrasound systems, medical imaging system. The products in medical imagining systems include computer tomography systems, Magnetic resonance imagining systems, integrated CT scan systems and data acquisition systems.
Segments for Global Eye Melanoma Market
The Global Eye Melanoma Market is segmented on the basis of the site, diagnosis, treatment, and end user.
On the basis of the site, the market is segmented into sclera, retina, uvea, and others. On the basis of the diagnosis, the market is categorized into eye exam, imaging, biopsy, and others. The eye exam segment is sub-segmented into ophthalmoscopy, slit-lamp biomicroscopy, and others. The imaging segmented is sub-segmented into ultrasound, fluorescein angiography, fundus autofluorescence, optical coherence tomography, and others. On the basis of the treatment, the market is segmented into radiation therapy, laser treatment, surgery, and others. The radiation therapy segment is sub-segmented into episcleral plaque therapy, external beam radiation therapy, and others. The surgery segment is sub-segmented into iridectomy, choroidectomy, enucleation, and others. On the basis of end users, the market is segmented into hospitals & clinics, academic institutes, and others.
Regional Analysis for Global Eye Melanoma Market
The America region dominates the global eye melanoma market due to increase in prevalence of disease and huge healthcare expenditure. Moreover, increasing number of patients, changing lifestyle have driven the growth of the American market. Apart from this, the presence of the major market players like the GENERAL ELECTRIC, Analogic Corporation, Bellicum Pharmaceutical, Astra Zeneca Plc, NOVADAQ Technologies Inc. within the region increases the market growth.
Europe is the second largest eye melanoma market owing to increasing in research and development, huge patient population and well-developed healthcare.
The Asia pacific is fastest growing region for the eye melanoma market as the presence of a huge patient population, continuously developing economies and rising healthcare expenditure boosts the market.
The Middle East & Africa is the least growing region in global eye melanoma market due to the presence of poor economies and stringent government policies, lack of awareness especially in the Africa region. The Middle East holds a majority of the market due to a well-developed healthcare sector by economies like Qatar, Kuwait, Dubai, Saudi Arabia and others.
To Browse Complete Report visit https://www.marketresearchfuture.com/reports/eye-melanoma-market-5570
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Hadapsar, Pune – 411028
Maharashtra, India
Phone: +1 646 845 9312
